Terumo (OTCMKTS:TRUMY) Stock Crosses Below 50 Day Moving Average – What’s Next?

Terumo Corp. (OTCMKTS:TRUMY)’s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $13.68 and traded as low as $13.6250. Terumo shares last traded at $13.7255, with a volume of 94,402 shares traded.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Terumo to a “hold” rating in a research note on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.

Terumo Stock Up 2.0%

The company has a market capitalization of $20.25 billion, a PE ratio of 22.50 and a beta of 0.67. The company’s fifty day moving average is $13.68 and its 200-day moving average is $13.69. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings results on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, meeting the consensus estimate of $0.11. The business had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.17%. As a group, analysts predict that Terumo Corp. will post 0.7 EPS for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.